Prism Biolab Co (TSE:206A) Total Equity: 円2,129.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:206A Prism Biolab Co Ltd TSE:206A
11 GF Score
Price 円144.00
! 2 Warning Signs
View Full Analysis

What is Prism Biolab Co Total Equity?

Prism Biolab Co TSE:206A -1.37% 11 Total Equity is 円2,129.8 Mil as of Mar. 2026. GuruFocus rates TSE:206A with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Prism Biolab Co's total equity for the quarter that ended in Mar. 2026 was 円2,129.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Prism Biolab Co Total Equity Historical Data

* Premium members only.

The historical data trend for Prism Biolab Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Biolab Co Total Equity Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24 Sep25
Total Equity
1,674.93 1,148.02 3,502.90 2,708.83

Prism Biolab Co Quarterly Data
Sep22 Sep23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,057.71 2,731.58 2,708.83 2,439.75 2,129.77
TSE:206A
11GF Score
Prism Biolab Co Ltd TSE:206A
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prism Biolab Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Prism Biolab Co's Total Equity for the fiscal year that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=3085.692-376.863
=2,708.8

Prism Biolab Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2586.325-456.557
=2,129.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円2,129.8 Mil mean?
Prism Biolab Co (TSE:206A) has a Total Equity of 円2,129.8 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Prism Biolab Co and its competitors.
Is Prism Biolab Co's Total Equity too high?
Prism Biolab Co's current Total Equity is 円2,129.8 Mil. Overall, Prism Biolab Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Prism Biolab Co's Total Equity compare to VRTX and REGN?
Prism Biolab Co's Total Equity of 円2,129.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Prism Biolab Co and its competitors. Prism Biolab Co's current Total Equity is 円2,129.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Biolab Co stock overvalued right now?
Prism Biolab Co (TSE:206A) has a current Total Equity of 円2,129.8 Mil. The current Total Equity is 円2,129.8 Mil. Prism Biolab Co's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Prism Biolab Co (TSE:206A), the current Total Equity is 円2,129.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prism Biolab Co Business Description

Address 26-1, Muraoka-Higashi 2-chome, Kanagawa Prefecture, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.
11GF Score

Get the complete analysis for TSE:206A

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円144.00
Price